Search research articles
Contact Us
Filters
Showing results (91-100 of 599) with videos related to
Page
of 60
Sort By:
Advances in Hematology
|
April 5, 2011
Micro-RNA Expression and Function in Lymphomas
Sukhinder K Sandhu, Carlo M Croce, Ramiro Garzon
Pharmacological Reviews
|
November 25, 2025
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response
Esmerina Tili, Jean-Jacques Michaille, Carlo M Croce
Trends in Cancer
|
May 24, 2016
Novel mechanisms of regulation of miRNAs in CLL
Veronica Balatti, Mario Acunzo, Yuri Pekarky, et al.
Frontiers in Cell and Developmental Biology
|
June 28, 2021
The MicroRNA Family Gets Wider: The IsomiRs Classification and Role
Luisa Tomasello, Rosario Distefano, Giovanni Nigita, et al.
Oncotarget
|
February 22, 2012
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
Rosa Visone, Angelo Veronese, Veronica Balatti, et al.
Aging
|
November 18, 2016
The Fhit protein: an opportunity to overcome chemoresistance
Eugenio Gaudio, Francesco Paduano, Carlo M Croce, et al.
Annals of the New York Academy of Sciences
|
October 27, 2010
MicroRNAs in cancer: personalizing diagnosis and therapy
S Patrick Nana-Sinkam, Muller Fabbri, Carlo M Croce
Birth Defects Research. Part C, Embryo Today : Reviews
|
July 19, 2006
MicroRNAs: fundamental facts and involvement in human diseases
Gianpiero Di Leva, George A Calin, Carlo M Croce
Journal of Cell Science
|
May 23, 2007
MicroRNAs in human cancer: from research to therapy
Massimo Negrini, Manuela Ferracin, Silvia Sabbioni, et al.
Carcinogenesis
|
April 28, 2017
Small non-coding RNA and cancer
Giulia Romano, Dario Veneziano, Mario Acunzo, et al.
Page
of 60
Search research articles
Search
Showing results (91-100 of 599) with videos related to
Sort By:
Page
of 60
Advances in Hematology
|
April 5, 2011
Micro-RNA Expression and Function in Lymphomas
Sukhinder K Sandhu, Carlo M Croce, Ramiro Garzon
Pharmacological Reviews
|
November 25, 2025
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response
Esmerina Tili, Jean-Jacques Michaille, Carlo M Croce
Trends in Cancer
|
May 24, 2016
Novel mechanisms of regulation of miRNAs in CLL
Veronica Balatti, Mario Acunzo, Yuri Pekarky, et al.
Frontiers in Cell and Developmental Biology
|
June 28, 2021
The MicroRNA Family Gets Wider: The IsomiRs Classification and Role
Luisa Tomasello, Rosario Distefano, Giovanni Nigita, et al.
Oncotarget
|
February 22, 2012
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
Rosa Visone, Angelo Veronese, Veronica Balatti, et al.
Aging
|
November 18, 2016
The Fhit protein: an opportunity to overcome chemoresistance
Eugenio Gaudio, Francesco Paduano, Carlo M Croce, et al.
Annals of the New York Academy of Sciences
|
October 27, 2010
MicroRNAs in cancer: personalizing diagnosis and therapy
S Patrick Nana-Sinkam, Muller Fabbri, Carlo M Croce
Birth Defects Research. Part C, Embryo Today : Reviews
|
July 19, 2006
MicroRNAs: fundamental facts and involvement in human diseases
Gianpiero Di Leva, George A Calin, Carlo M Croce
Journal of Cell Science
|
May 23, 2007
MicroRNAs in human cancer: from research to therapy
Massimo Negrini, Manuela Ferracin, Silvia Sabbioni, et al.
Carcinogenesis
|
April 28, 2017
Small non-coding RNA and cancer
Giulia Romano, Dario Veneziano, Mario Acunzo, et al.
Page
of 60